1Assistant Professor, Department of Pharmacy, Avadh Institute of Medical Technology and Hospital, Lucknow, Uttar Pradesh206026
2Associate Professor, Department of Pharmacy, Saroj Institute of Technology and Management, Lucknow, Uttar Pradesh206002
3Associate Professor, Department of Pharmacy, Saroj Institute of Technology and Management, Lucknow, Uttar Pradesh206002
*Corresponding Author E-mail: bhavanadubey91@gmail.com
Online published on 19 December, 2025.
In recent years, numerous pyrazole derivatives have been identified in scientific literature as potent anti-inflammatory agents. Among these, pyrazolyl sulfonamides and pyrazolyl derivatives of urea have demonstrated significant anti-inflammatory properties and the ability to inhibit p38α MAP kinase. This study aimed to determine the structures of these compounds using spectral data and evaluate their anti-inflammatory activity through in vitro assays. The anti-denaturation assay using bovine serum albumin (BSA) and the p38α MAP kinase assay were employed to screen the compounds for anti-inflammatory potential. Compounds that exhibited promising results in these initial assessments were further evaluated for their ability to reduce inflammation, induce ulcers, cause lipid damage, and suppress TNF-α. The findings highlight the therapeutic potential of these pyrazole derivatives in the treatment of inflammatory diseases and provide a basis for further development of novel anti-inflammatory agents.
Pyrazole, Anti-Inflammatory, Bovine Serum Albumin, Ulcers